AzTrials
AzTrials

Stoma - IleostomyNCT01957475

Investigation of Two Newly Developed 2-piece Convex Baseplates in Subjects With Ileostomy

A study testing Coloplast Test product Y and Coloplast Test product Z in people with Stoma - Ileostomy, run by Coloplast A/S at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the current investigation is to develop new soft and more flexible 2-piece convex ostomy appliances Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stoma - Ileostomy
What is being tested?
Coloplast Test product Y and Coloplast Test product Z
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteDenmark
Study dates
Apr 2013to May 2013
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Have given written informed consent and signed letter of authority.
  • Are at least 18 years of age and have full legal capacity.
  • Have had their ileostomy for at least 3 months.
  • Have used a 2-piece convex ostomy product during the last month.
  • Are willing and able to comply with investigation procedures.
  • Have an ileostomy with a diameter of 30 mm or less.
  • Have experienced leakage (seeping) under the baseplate at least 2 times during the last two weeks.

Who cannot join

  • Currently suffering from peristomal skin problems (i.e. bleeding or broken skin).
  • Currently receiving or have within the past 2 month received radio- and/or chemotherapy.
  • Currently receiving or have within the past month received local (peristomal area) or systemic steroid treatment.
  • Are pregnant or breastfeeding.
  • Have a loop ostomy (also called double-barrel or ostomy with two outlets).
  • Known hypersensitivity toward any of the test products.
  • Participating in other interventional clinical investigations or have previously participated in this investigation.

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Coloplast A/S

    Humlebæk, 3050

Other trials in Denmark

About this study

The aim of the current investigation is to develop new soft and more flexible 2-piece convex ostomy appliances

Being tested
Coloplast Test product Y, Coloplast Test product Z

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Coloplast Test product YDevice

    Also called Coloplast 2-piece Convex appliance Test product Y

    Coloplast Test product Y is a newly developed 2-piece convex ostomy appliance

  • Coloplast Test product ZDevice

    Also called Coloplast 2-piece convex appliance test product Z

    Coloplast Test product Z is a newly developed 2-piece convex ostomy appliance

Study groups in NCT01957475
Study groupRoleWhat they receive
First Coloplast Test product Z; then Coloplast Test product YExperimentalThe subjects first test Coloplast Test product Z and after cross-over Coloplast Test product Y
Receives: Device: Coloplast Test product Y; Device: Coloplast Test product Z
First Coloplast Test product Y, Then Coloplast Test product ZExperimentalThe subjects first test test product Y and after cross-over test product Z
Receives: Device: Coloplast Test product Y; Device: Coloplast Test product Z

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Degree of Leakage

    The degree of leakage is measured using a 32-point scale developed by Coloplast A/S, where 0 represents No leakage (best possible outcome) and 32 points represents full-plate leakage (worst possible outcome).

    The degree of leakage was measured at each baseplate change.

    Measured: 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2013 (estimated)
  2. Study startApr 2013
  3. Primary completionMay 2013
  4. Study completionMay 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01957475
Sponsor's protocol ID
CP240
Status last verified
Aug 2016
First submitted
6 Aug 2013
Last updated
20 Sep 2016
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Coloplast Test product Y and Coloplast Test product Z in people with Stoma - Ileostomy, run by Coloplast A/S at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 11 Aug 2014). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Degree of Leakage (time frame: 14 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Sep 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in